Serial Number 78151737
Registration 2802294
800

Registration Progress

Application Filed
Aug 7, 2002
Under Examination
Approved for Publication
Sep 24, 2003
Published for Opposition
Oct 14, 2003
Registered
Jan 6, 2004

Basic Information

Serial Number
78151737
Registration Number
2802294
Filing Date
August 7, 2002
Registration Date
January 6, 2004
Published for Opposition
October 14, 2003
Renewal Date
January 6, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 30, 2024
Registration
Registered
Classes
005

Rights Holder

GRIFOLS THERAPEUTICS LLC

16
Address
79 TW ALEXANDER DRIVE
4101 RESEARCH COMMONS
RESEARCH TRIANGLE PARK, NC 27709

Ownership History

Bayer Aktiengesellschaft

Original Applicant
09
Leverkusen-Bayerwerk DE

Bayer Aktiengesellschaft

Owner at Publication
09
Leverkusen-Bayerwerk DE

Bayer Aktiengesellschaft

Original Registrant
09
Leverkusen-Bayerwerk DE

BAYER HEALTHCARE LLC

New Owner After Registration #1
16
PITTSBURGH, PA

Talecris Biotherapeutics, Inc

New Owner After Registration #2
03
Research Triangle Park, NC

GRIFOLS THERAPEUTICS INC.

New Owner After Registration #3
03
RESEARCH TRIANGLE PARK, NC

GRIFOLS THERAPEUTICS LLC

New Owner After Registration #4
16
RESEARCH TRIANGLE PARK, NC

Legal Representation

Attorney
Karin Segall

USPTO Deadlines

Next Renewal Deadline
3104 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2004-01-06)
Due Date
January 06, 2034
Grace Period Ends
July 06, 2034

Application History

40 events
Date Code Type Description
Jan 1, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 30, 2024 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 30, 2024 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 30, 2024 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Apr 30, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 8, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED
Jan 6, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 26, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 19, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 5, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 10, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 10, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 31, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 22, 2017 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 20, 2014 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 20, 2014 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2014 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 13, 2013 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 13, 2013 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 13, 2013 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 13, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2013 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Dec 2, 2013 E89R I TEAS SECTION 8 & 9 RECEIVED
Jul 3, 2013 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 25, 2009 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 25, 2009 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 17, 2009 E815 I TEAS SECTION 8 & 15 RECEIVED
Jun 6, 2007 CFIT O CASE FILE IN TICRS
Aug 1, 2006 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 1, 2006 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2006 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 6, 2004 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 14, 2003 PUBO A PUBLISHED FOR OPPOSITION
Sep 24, 2003 NPUB O NOTICE OF PUBLICATION
Mar 27, 2003 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2003 MAIL I PAPER RECEIVED
Jan 2, 2003 CNSL F LETTER OF SUSPENSION MAILED
Dec 29, 2002 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceutical preparations and substances, namely, immunoglobulin, hemostatic agents [, vaccines for human use ]

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005